ScienceDex / Researcher record
Mark B Geyer
FY2026 NIH rank #37,740
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $865,308 | 1 | #17,630 |
| 2025 | $402,600 | 1 | #36,293 |
| 2026 | $402,600 | 1 | #37,740 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20251 record
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14135064Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Mark B Geyer as a PI. Multi-PI records show the full award amount for context.
- 5R01CA291796-02R01Co-investigatorDevelopment of chimeric antigen receptor T cells targeting cell surface U5 snRNP for the treatment of acute myeloid leukemia$402.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Mark B Geyer as a PI.
FY2026 award administered by Memorial Sloan Kettering Cancer Center (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMemorial Sloan Kettering Cancer Center
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Mark B Geyer.